Literature DB >> 9355058

Preliminary results of the use of a two-stage treadmill test as a clinical diagnostic tool in the differential diagnosis of lumbar spinal stenosis.

J M Fritz1, R E Erhard, A Delitto, W C Welch, P E Nowakowski.   

Abstract

This study assesses the ability of a two-stage treadmill test to distinguish stenotic from nonstenotic subjects by capitalizing on the postural dependency of stenotic symptoms. Forty-five subjects (26 stenotic, 19 nonstenotic) participated. An earlier onset of symptoms with level walking (p = 0.0009), increased total walking time on an inclined treadmill (p = 0.014), and prolonged recovery time after level walking (p = 0.001) were significantly associated with stenosis. Only one of four self-reported postural variables were significantly associated with stenosis. Linear discriminant analysis performed using the treadmill variables resulted in the correct classification of 76.9 and 94.7% of stenotic and nonstenotic subjects, respectively. Likelihood ratios for all treadmill variables were > 2.50, and < 2.00 for all self-report variables. A two-stage treadmill test may be useful in the differential diagnosis of lumbar stenosis, and clinical measurement of the postural nature of symptoms seems to be superior to subjects' self-reports.

Entities:  

Mesh:

Year:  1997        PMID: 9355058

Source DB:  PubMed          Journal:  J Spinal Disord        ISSN: 0895-0385


  15 in total

1.  Loading is more effective than posture in lumbar spinal stenosis: a study with a treadmill equipment.

Authors:  Hasan Oğuz; Funda Levendoğlu; Tunç Cevat Oğün; Aysenur Tantuğ
Journal:  Eur Spine J       Date:  2007-02-02       Impact factor: 3.134

2.  Differential diagnosis and management of an older runner with an atypical neurodynamic presentation: a case for clinical reasoning.

Authors:  Jonathan Sylvain; Michael P Reiman
Journal:  Int J Sports Phys Ther       Date:  2015-04

3.  Common iliac artery occlusion presenting with back and leg pain: case report and differential diagnosis considerations for neurogenic/vascular claudication.

Authors:  Erin L Huml; Robert A Davies; Gary A Kearns; Shannon M Petersen; Jean-Michel Brismée
Journal:  J Man Manip Ther       Date:  2018-10-08

4.  The role of MRI in musculoskeletal practice: a clinical perspective.

Authors:  Gail Dean Deyle
Journal:  J Man Manip Ther       Date:  2011-08

5.  Quantification of walking ability in subjects with neurogenic claudication from lumbar spinal stenosis--a comparative study.

Authors:  James Rainville; Lisa A Childs; Enrique B Peña; Pradeep Suri; Janet C Limke; Cristin Jouve; David J Hunter
Journal:  Spine J       Date:  2011-12-29       Impact factor: 4.166

Review 6.  Physical therapy interventions for degenerative lumbar spinal stenosis: a systematic review.

Authors:  Luciana Gazzi Macedo; Abraham Hum; Laura Kuleba; Joey Mo; Linda Truong; Mankeen Yeung; Michele C Battié
Journal:  Phys Ther       Date:  2013-07-25

7.  Correlations between sedimentation sign, dural sac cross-sectional area, and clinical symptoms of degenerative lumbar spinal stenosis.

Authors:  Sangbong Ko
Journal:  Eur Spine J       Date:  2017-11-07       Impact factor: 3.134

8.  A randomised controlled trial of post-operative rehabilitation after surgical decompression of the lumbar spine.

Authors:  Anne F Mannion; Raymond Denzler; Jiri Dvorak; Markus Müntener; Dieter Grob
Journal:  Eur Spine J       Date:  2007-06-26       Impact factor: 3.134

9.  Assessment and management of neurogenic claudication associated with lumbar spinal stenosis in a UK primary care musculoskeletal service: a survey of current practice among physiotherapists.

Authors:  Christine M Comer; Anthony C Redmond; Howard A Bird; Philip G Conaghan
Journal:  BMC Musculoskelet Disord       Date:  2009-10-01       Impact factor: 2.362

10.  The efficacy of physical therapy and physical therapy plus calcitonin in the treatment of lumbar spinal stenosis.

Authors:  Fusun Sahin; Figen Yilmaz; Nurdan Kotevoglu; Banu Kuran
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.